| Literature DB >> 34008044 |
Yuki Arakawa1,2, Satoshi Masutani3, Koichi Oshima4, Yuichi Mitani4, Makiko Mori4, Kohei Fukuoka4, Koichi Moriwaki3, Motohiro Kato5, Katsuaki Taira6, Yutaka Tanami7, Atsuko Nakazawa8, Katsuyoshi Koh4.
Abstract
Osteonecrosis (ON), a long-term complication of acute lymphoblastic leukemia (ALL) treatment affects patients' quality of life. Although the incidence of any ON, including asymptomatic, was 21.7% among children with ALL in the U.S., the actual incidence and risk factors in Asia remain unknown. For over 11 years, we performed hip magnetic resonance imaging (MRI) screening to detect asymptomatic ON while initiating maintenance chemotherapy in newly diagnosed children with ALL. Overall, 164 of 175 patients underwent hip MRI screening. The incidence of symptomatic or any ON was 3.0% and 11.6%, respectively. Asymptomatic ON in patients < 10 and ≥ 10 years old was 4.0% and 35.9%, respectively (P < 0.001). In multivariate analysis, age ≥ 10 years was the only significant risk factor. Asymptomatic ON with necrosis of > 30% of the epiphyseal surface of the femoral head was detected in four patients (2.4%). All were ≥ 10 years. Three of them progressed to severe symptomatic ON. The incidence of any ON in Asia may be lower than that seen in the only screening study in the U.S. Future studies should clarify factors affecting such regional differences and develop an effective approach to avoid the progression of ON in children with ALL.Entities:
Keywords: Hip osteonecrosis; Magnetic resonance imaging screening; Pediatric leukemia/lymphoma
Year: 2021 PMID: 34008044 DOI: 10.1007/s12185-021-03163-1
Source DB: PubMed Journal: Int J Hematol ISSN: 0925-5710 Impact factor: 2.490